Celcuity, Inc. (CELC)
82.58
-0.12
(-0.15%)
USD |
NASDAQ |
Sep 16, 16:00
83.89
+1.31
(+1.59%)
After-Hours: 05:33
Celcuity Enterprise Value : 4.040B for Sept. 16, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 16, 2026 | 4.040B |
| September 15, 2026 | 4.046B |
| September 14, 2026 | 4.087B |
| September 11, 2026 | 4.083B |
| September 10, 2026 | 4.183B |
| September 09, 2026 | 4.407B |
| September 08, 2026 | 4.551B |
| September 04, 2026 | 4.682B |
| September 03, 2026 | 4.718B |
| September 02, 2026 | 4.707B |
| September 01, 2026 | 4.500B |
| August 31, 2026 | 4.357B |
| August 28, 2026 | 4.327B |
| August 27, 2026 | 4.562B |
| August 26, 2026 | 4.652B |
| August 25, 2026 | 4.514B |
| August 24, 2026 | 4.442B |
| August 21, 2026 | 4.576B |
| August 20, 2026 | 4.431B |
| August 19, 2026 | 4.582B |
| August 18, 2026 | 4.562B |
| August 17, 2026 | 4.523B |
| August 14, 2026 | 4.501B |
| August 13, 2026 | 4.237B |
| August 12, 2026 | 4.505B |
| Date | Value |
|---|---|
| August 11, 2026 | 4.311B |
| August 10, 2026 | 4.442B |
| August 07, 2026 | 4.539B |
| August 06, 2026 | 4.562B |
| August 05, 2026 | 4.546B |
| August 04, 2026 | 4.525B |
| August 03, 2026 | 4.292B |
| July 31, 2026 | 4.226B |
| July 30, 2026 | 4.288B |
| July 29, 2026 | 4.074B |
| July 28, 2026 | 4.034B |
| July 27, 2026 | 4.025B |
| July 24, 2026 | 4.042B |
| July 23, 2026 | 4.322B |
| July 22, 2026 | 4.410B |
| July 21, 2026 | 4.486B |
| July 20, 2026 | 4.305B |
| July 17, 2026 | 4.324B |
| July 16, 2026 | 4.320B |
| July 15, 2026 | 4.477B |
| July 14, 2026 | 5.433B |
| July 13, 2026 | 5.078B |
| July 10, 2026 | 5.263B |
| July 09, 2026 | 5.554B |
| July 08, 2026 | 5.328B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Sarepta Therapeutics, Inc. | 2.344B |
| Replimune Group, Inc. | 1.005B |
| Twist Bioscience Corp. | 8.894B |
| Beam Therapeutics, Inc. | 1.480B |
| Vera Therapeutics, Inc. | 1.862B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -78.86M |
| Total Expenses (Quarterly) | 78.86M |
| EPS Diluted (Quarterly) | -1.439 |
| Earnings Yield | -5.21% |
| Normalized Earnings Yield | -5.029 |